For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240918:nRSR6632Ea&default-theme=true
RNS Number : 6632E Science in Sport PLC 18 September 2024
Science in Sport plc
("Science in Sport" or the "Company")
Director/PDMR Shareholding
Science in Sport plc (AIM: SIS), the premium performance nutrition company
serving elite athletes, sports enthusiasts and the gym lifestyle community,
announces that it has been notified of the following transaction by
Christopher Welsh, Chief Financial Officer. Following this transaction
Christopher Welsh holds 208,284 ordinary shares in the Company, representing
0.09% of the issued share capital.
The information below set out in accordance with the requirement of the EU
Market Abuse Regulation provides further detail.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No.
596/2014
1 Details of the person discharging managerial responsibilities/person closely
associated
a. Name Christopher Welsh
2 Reason for notification
a. Position/Status Chief Financial Officer
b. Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Science in Sport plc
b. LEI 213800FWYWBJFJPPJ981
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the financial instrument, type of instrument Ordinary Shares of 10 pence each
Identification Code
ISIN: GB00BBPV5329
b. Nature of the transaction Purchase of shares
c. Price(s) and volume(s)
Price(s) Volume(s)
24.5 pence 61,225
d. Aggregated information n/a single transaction
- Aggregated Volume
- Price
e. Date of the transaction 17 September 2024
f. Place of the transaction London Stock Exchange, AIM
For further information:
Science in Sport plc T: +44 (0) 20 7400 3700
Daniel Wright, Executive Chairman
Daniel Lampard, Chief Operating Officer
Christopher Welsh, Chief Financial Officer
Panmure Liberum Limited (Nominated Adviser and Broker) T: +44 (0) 20 3100 2000
Richard Lindley
John More
Anake Singh
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition
business that develops, manufactures, and markets innovative nutrition
products for professional athletes, sports and fitness enthusiasts and the
active lifestyle community. The Company has two highly regarded brands, PhD
Nutrition, a premium active-nutrition brand targeting the active lifestyle
community, and SiS, a leading endurance nutrition brand among elite athletes
and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com
digital platforms, third-party online sites, including Amazon and eBay, and
extensive retail distribution in the UK and internationally, including major
supermarkets, high street chains and specialist sports retailers. This
omnichannel footprint enables the Company to address the full breadth of the
sports nutrition market.
PhD is one of the UK's leading active nutrition brands with a reputation for
high quality and product innovation. The brand has grown rapidly since its
launch in 2005. The range now comprises powders, bars, and supplements,
including the high protein, low sugar range, PhD Smart.
SiS, a leading endurance nutrition business founded in 1992, has a core range
comprising gels, powders and bars focused on energy, hydration, and recovery.
SiS is an official endurance nutrition supplier to over 320 professional
teams, organisations, and national teams worldwide. SiS supplies more than 150
professional football clubs in the UK, Europe, and the USA.
SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and
Tottenham Hotspur and CGC Nice football clubs.
For further information, please visit phd.com and scienceinsport.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGUGDCLSBDGSI